Coverage
-
August 08, 2014
Google Inc. has agreed to spend a total of $250 million on product quality control to end a suit brought by shareholders after its $500 million settlement with the U.S. government for allowing Canadian pharmaceutical companies to advertise on its site, according to documents filed in California federal court Thursday.
1 other articles on this case.
View all »